CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ (4,792)	$ 52,327
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization, including amortization of capitalized loan costs	27,305	26,650
(Gain) loss on sale of real estate and other investments	577	(60,159)
Share-based compensation expense	749	1,519
Other, net	526	332
Changes in other assets and liabilities:
Other assets	1,778	1,783
Accounts payable and accrued expenses	(1,740)	(648)
Net cash provided by operating activities	24,403	21,804
CASH FLOWS FROM INVESTING ACTIVITIES
Increase in mortgages and real estate related notes receivable	(7,279)	0
Net proceeds from sale of real estate and other investments	18,251	141,587
Proceeds from insurance	1,635	620
Payments for improvements of real estate investments	(21,810)	(11,237)
Other investing activities	171	214
Net cash provided by (used by) investing activities	(9,032)	131,184
CASH FLOWS FROM FINANCING ACTIVITIES
Principal payments on mortgages payable	(1,529)	(20,734)
Proceeds from revolving lines of credit	40,556	35,969
Principal payments on revolving lines of credit	(30,198)	(6,000)
Principal payments on notes payable	0	(100,000)
Repurchase of common shares	(4,703)	(1,022)
Distributions paid to common shareholders	(10,923)	(10,917)
Distributions paid to preferred shareholders	(1,607)	(1,607)
Distributions paid to Series D preferred unitholders	(160)	(160)
Distributions paid to noncontrolling interests – Operating Partnership and Series E preferred units	(2,300)	(2,413)
Other financing activities	(28)	(153)
Net cash used by financing activities	(10,892)	(107,037)
NET INCREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH	4,479	45,951
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT BEGINNING OF PERIOD	9,269	11,891
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT END OF PERIOD	13,748	57,842
SUPPLEMENTARY SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Accrued capital expenditures	3,153	3,804
Operating partnership units converted to common shares	(398)	(697)
Distributions declared but not paid to common shareholders	11,805	11,668
Series E preferred units converted to common shares	(702)	(935)
Retirement of shares withheld for taxes	118	161
Involuntary conversion of assets	160	0
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid for interest	8,302	6,168
Cash and cash equivalents	12,682	8,939
Restricted cash	1,066	48,903
Total cash, cash equivalents and restricted cash	$ 13,748	$ 57,842